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Mitochondrial function provides instructive
signals for activation-induced B-cell fates
Kyoung-Jin Jang1, Hiroto Mano1, Koji Aoki2, Tatsunari Hayashi1, Akihiko Muto3,4, Yukiko Nambu1,w,
Katsu Takahashi5, Katsuhiko Itoh6, Shigeru Taketani7, Stephen L. Nutt8,9, Kazuhiko Igarashi3,4,
Akira Shimizu1 & Manabu Sugai1,10
During immune reactions, functionally distinct B-cell subsets are generated by stochastic
processes, including class-switch recombination (CSR) and plasma cell differentiation (PCD).
In this study, we show a strong association between individual B-cell fates and mitochondrial
functions. CSR occurs speciﬁcally in activated B cells with increased mitochondrial mass and
membrane potential, which augment mitochondrial reactive oxygen species (mROS),
whereas PCD occurs in cells with decreased mitochondrial mass and potential. These events
are consequences of initial slight changes in mROS in mitochondriahigh B-cell populations. In
CSR-committed cells, mROS attenuates haeme synthesis by inhibiting ferrous ion addition to
protoporphyrin IX, thereby maintaining Bach2 function. Reduced mROS then promotes PCD
by increasing haeme synthesis. In PCD-committed cells, Blimp1 reduces mitochondrial mass,
thereby reducing mROS levels. Identifying mROS as a haeme synthesis regulator increases
the understanding of mechanisms regulating haeme homeostasis and cell fate determination
after B-cell activation.
DOI: 10.1038/ncomms7750 OPEN
1 Department of Experimental Therapeutics, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, 54 Shogoin-Kawahara-cho,
Sakyo-ku, Kyoto 606-8507, Japan. 2Division of Pharmacology, School of Medicine, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui
910-1193, Japan. 3Department of Biochemistry, Tohoku University Graduate School of Medicine, Seiryo-machi 2-1, Aoba-ku, Sendai, Miyagi 980-8575, Japan.
4 CREST, Japan Science and Technology Agency, Seiryo-machi 2-1, Aoba-ku, Sendai, Miyagi 980-8575, Japan. 5Department of Oral and Maxillofacial Surgery,
Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. 6Department of Clinical Molecular Biology, Graduate School of
Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. 7Department of Biotechnology, Kyoto Institute of Technology,
Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan. 8 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria 3052, Australia. 9Department of
Medical Biology, University of Melbourne, Victoria 3010, Australia. 10Division of Molecular Genetics, Department of Biochemistry and Bioinformative Sciences,
School of Medicine, University of Fukui, 23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan. wPresent address: Bioprocessing Technology
Institute, A*STAR20 Biopolis Way #06-01 Centros, Singapore 138668, Singapore. Correspondence and requests for materials should be addressed to
M.S. (email: msugai@u-fukui.ac.jp).
NATURE COMMUNICATIONS | 6:6750 | DOI: 10.1038/ncomms7750 |www.nature.com/naturecommunications 1
& 2015 Macmillan Publishers Limited. All rights reserved.
O
n antigen challenge, naı¨ve B lymphocytes undergo
diversiﬁcation of their antigen receptor via somatic
hypermutation (SHM), alteration of immunoglobulin
function by class-switch recombination (CSR)1–7 and
differentiation into antibody-secreting plasma cells or memory
B cells8–13. Although several important transcription factors
involved in these processes have been identiﬁed, the interrelations
in the regulatory network that determine cell fates after B-cell
activation remain elusive14–17. Pax5 and Bach2 are required for
CSR because ablations of these genes in B cells destroy the ability
of the cell to undergo CSR2,18. Pax5 and Bach2 also inhibit
plasma cell differentiation (PCD) by inhibiting the transcription
of Blimp1, a master gene for PCD2,19–22. Irf4 and Xbp1 act in
concert with Blimp1 to establish plasma cell fate8,11,13,23,24.
However, Blimp1 represses Pax5 expression in differentiating
plasma cells9,10. The transcription factor Irf4 plays a pivotal
regulatory role in these processes because it is required for afﬁnity
maturation, CSR and PCD11–13. An intermediate amount of Irf4
induces the expression of Bcl6 and activation-induced cytidine
deaminase (AID), whereas a high amount induces the expression
of Blimp1 (refs 12,13). CSR and SHM are initiated by the AID-
dependent cytidine deamination of DNA in immunoglobulin
loci1,3–6. Bcl6 is required for germinal-centre (GC) B-cell
development. During the GC reaction, B cells undergo SHM at
their immunoglobulin loci, and high-afﬁnity immunoglobulin-
bearing B cells are selected in a process called afﬁnity
maturation25–29. Mutually exclusive expression of Bcl6 and
Blimp1 is established by the mutual inhibition of expression.
Although the essential gene sets for various B-cell fates after
activation and a regulatory network that inhibits unselected fates
have been described, the instructive signals for the initiation of
the respective B-cell fates or transitions between them are not
completely known.
Metabolism encompasses the generation of energy via
catabolism and of macromolecules via anabolism. Recent studies
have indicated more complex roles of metabolic pathways or
metabolites in cell differentiation and function30–33. A shift
towards glycolysis occurs in macrophages activated by
lipopolysaccharide (LPS), inducing interleukin-1b production in
a hypoxia-inducible factor 1-alpha-dependent manner. Inhibition
of glycolysis using 2-deoxyglucose suppresses interleukin-1b
production via the reduction of succinate, an intermediate of
the tricarboxylic acid (TCA) cycle or the g-aminobutyric acid
shunt, and stabilizes HIF-1a (ref. 31). A strong bias towards
glycolysis over mitochondrial metabolism has also been observed
in haematopoietic stem cell (HSC) maintenance34, Th17
differentiation, tumour cell functions and interferon-g
production in activated T cells30. However, regulatory T cells
display a mixed metabolism that includes lipid oxidation,
oxidative phosphorylation and glycolysis30. In addition to
generating various metabolites in mitochondria, mitochondria-
derived reactive oxygen species (mROS) are now understood to
function as signalling molecules35. This indicates that
mitochondria play fundamental roles in cell differentiation and
function. In activated B cells, haeme strongly induces PCD by
inhibiting Bach2 function36.
Because activated B cells differentiate into various cell types in
a stochastic manner15, we speculated that stochastic changes in
some metabolic pathways would provide instructive signals to
activated B cells. In this study, we investigated the functions of
mitochondria in fate determination of activated B cells and
attempted to identify the signals directing B-cell fate towards CSR
or PCD. We ﬁrst observed that differences in mitochondrial
status predicted the direction of the committed cells toward either
pathway. CSR occurred in activated B cells with increased
mitochondrial mass and membrane potential, whereas PCD
occurred in cells with decreased mitochondrial mass and
potential. However, differences in mitochondrial mass and
membrane potential were the consequences of slight initial
changes in generating mROS within the mitochondriahigh B-cell
population. Activated mitochondriahigh B cells with higher
amounts of mROS maintained increased mitochondrial mass
and membrane potential, whereas cells with lower amounts
displayed decreased mitochondrial mass and potential. Thus,
slight differences in mROS were the initial signal in cell fate
determination after B-cell activation. Notably, the choice for the
B-cell fate of PCD or CSR was dependent on mitochondrial
functional activity that regulated an intracellular ROS level, which
suppressed haeme synthesis. These results suggest that
mitochondria contribute to B-cell fate determination via the
integration of instructive and cell-intrinsic stochastic signals by
regulating haeme and ROS levels.
Results
Activation-dependent generation of three B-cell populations.
Because alterations of metabolic pathways or metabolites are
involved in lineage commitment and cell differentiation31–33, we
hypothesized that intracellular metabolism plays some role in the
fate determination of the activated B cells. To test this possibility,
we investigated the involvement of mitochondria in B-cell fate
determination, considering that mitochondria produce various
metabolites including ATP, haeme and iron–sulfur clusters. First,
we evaluated total mitochondrial mass and membrane potential
after B-cell activation in vitro37 using MitoTracker Green and
DeepRed dyes, respectively. Mitochondrial mass and membrane
potential were increased, and a relatively uniform population
(called population 1, P1) was generated on day 1 of stimulation
with LPSþ IL-4 or anti-CD40þ IL-4 (Fig. 1a and Supplementary
Fig. 1b). On day 3 of stimulation, cells showing intermediate
levels of mitochondrial mass and membrane potential
(population 2, P2) increased in frequency. To investigate the
relationship between mitochondrial status and cell fates, we
examined the mitochondrial status of class switched cells (IgG1þ
cells) and plasma cells (CD138þ cells) on day 4 of stimulation.
IgG1þ cells preferentially belonged to the P1 population and
CD138þ cells to the P2 population (Fig. 1a and Supplementary
Fig. 1a–c), suggesting an association between P1 cells and CSR
and between P2 cells and PCD. Another minor population, called
P3 cells, also expressed IgG1. When the same assays were
performed using TMRM dye, instead of MitoTracker DeepRed,
essentially the same results were obtained (Supplementary
Fig. 2a). Next we evaluated total mitochondrial mass and
membrane potential after B-cell activation in vivo. Again, we
found P1, P2 and P3 cell populations among GC B cells during
the T-cell-dependent immune reaction. P1 cells preferentially
expressed IgG1, whereas P2 cells expressed CD138 (Fig. 1b). In
this case, IgG1-expressing plasmablasts were also observed among
P2 cells. This ﬁnding indicated that PCD occurred after IgG1
switching (Fig. 1b), because time-course analysis indicated that
P2 cells were generated later than P1 cells after B-cell activation
in vitro (Fig. 1a and Supplementary Fig. 1b). Same assays were
performed using TMRM dye, instead of MitoTracker DeepRed,
and essentially the same results were obtained (Supplementary
Fig. 1d). CD138þ cells were also enriched in P2 populations
within GL7þ GC B cells (Supplementary Fig. 3a). We further
examined mitochondrial status of splenic plasma cells in the same
mice as used for Fig. 1b. Proportions of P2 populations were
increased in plasma cells (Supplementary Fig. 3b). In the T-cell-
independent immune response, plasma cells were also observed
among P2 cells, but IgG3-expressing cells were observed among
P1 cells (Supplementary Fig. 3c). Thus, there was a strong
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Figure 1 | Activated B cells are subdivided into three groups according to the mitochondrial status. (a) Flow cytometric analysis of mitochondrial
membrane potential and size monitored by MitoTracker staining on the indicated day (top) or differentiation of the B cells monitored by CD138 and IgG1
expression on day 4 (bottom) in LPSþ IL-4-stimulated B cells. (b) Flow cytometric analysis of the mitochondrial status on the indicated day after
immunization (top) with NP-CGG and the differentiation status of population 1 (middle) and population 2 (bottom) in GC B cells (B220þCD38 FASþ ).
(c) Diagrammatic representation of experimental overview. Flow cytometric analysis of differentiation of sorted P1 and P2 cells. Data shown are
representative of three independent experiments.
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association between mitochondrial status and B-cell fate
determination. To evaluate this further, we investigated the
differential abilities of differentiation of P1 and P2 cells towards
CSR and PCD. To this end, we collected undifferentiated P1 and
P2 cells (indicated populations in Fig. 1c) that did not express
IgG1 and CD138 and stimulated them to differentiate. Consistent
with the above results (Fig. 1a,b), IgG1 was expressed in more
cells derived from P1 than from P2 cells (Fig. 1c), whereas CD138
was expressed in more cells derived from P2 than from P1 cells
(Fig. 1c). These results suggested that undifferentiated cells found
in P1 and P2 cell populations were committed to CSR and PCD,
respectively.
Modulation of mitochondrial function affects B-cell fate. To
investigate the contribution of mitochondrial metabolism to
B-cell fate determination, we blocked key enzymes of the
respiratory chain of mitochondria to reduce ATP levels.
The number of cells in the P1 cell fraction was increased by the
addition of the complex I inhibitors rotenone/metformin or the
complex V inhibitor oligomycin, whereas PCD was strongly
suppressed (Fig. 2a,b,i,j,m,n and Supplementary Fig. 4a). We also
inhibited the major metabolic pathways in mitochondria to
examine the involvement of distinctive catabolic pathways of
glucose or fatty acids in activated B-cell fate determination. We
found increases in P1 cell numbers and decreases in P2 cell
numbers after treatment with 2-deoxyglucose, a glucose analogue
that inhibits glycolysis, and etomoxir, an inhibitor of fatty acid
oxidation (Fig. 2a,c,d and Supplementary Fig. 4a). Similarly,
increased P1 cell numbers and decreased P2 cell numbers were
observed after treatment with methyl pyruvate, which provides
substrates for the TCA cycle, and methyl malate, which generates
NADPH (Fig. 2a,e,f and Supplementary Fig. 4a). In contrast, P2
cell generation and PCD were enhanced by the addition of the
antioxidant ascorbic acid, whereas CSR was suppressed (Fig. 2a,g
and Supplementary Fig. 4a).
Treatment of activated B cells with inhibitors of the
phosphatidylinositol 3-kinase (PI3K)–Akt pathway increased P1
cell numbers, enhanced CSR, reduced P2 cell numbers and
suppressed PCD (Fig. 2i,k,l and Supplementary Fig. 4a). These
results were consistent with earlier ﬁndings that the PI3K–Akt
pathway inhibits CSR and promotes PCD38.
We further investigated the relationship between haeme and
mitochondrial function in the control of B-cell fate determination
because haeme is a strong inducer of PCD via the inhibition of
Bach2 function36. Addition of haeme promoted skewed P2 cell
generation (Fig. 2a,h and Supplementary Fig. 4a). Because CSR
and PCD are inﬂuenced by cell proliferation, effects of various
reagents on the number of cell divisions were assessed using
carboxyﬂuorescein succinimidyl ester (CFSE)-labelled B cells. As
shown in Supplementary Fig. 5a–d,f,h–k, the proliferation of cells
was less affected by the presence of various reagents. Methyl
pyruvate inhibited cell proliferation but affected only PCD
(Supplementary Fig. 5g). For etomoxir-treated cells, reduced
CSR and PCD may be the results of reduced cell proliferation
(Supplementary Fig. 5e). These results collectively suggested that
commitment of activated B cells to CSR and PCD is controlled by
mitochondrial functions, as indicated by P1 and P2 populations,
irrespective of speciﬁc metabolic pathways.
Metabolic and gene expression proﬁles of P1 and P2 cells. To
characterize cells in P1 and P2 cell populations, in vitro-activated
P1 and P2 cells were investigated by transmission electron
microscopy (Fig. 3a). Mitochondrial mass increased in P1 cells,
consistent with the above results (Fig. 1). To further evaluate
mitochondrial function, we determined the oxygen consumption
rate (OCR) in P1 and P2 cells. Basal OCR, an indicator of oxi-
dative phosphorylation, was 1.4 times higher in P1 than in P2
cells (Fig. 3b). The basal extracellular acidiﬁcation rate (ECAR, a
marker of glycolysis) was signiﬁcantly higher in P1 than in P2
cells (Fig. 3b). ATP levels were consistently higher in P1 than in
P2 cells (Fig. 3c). We also investigated the roles of OCR and
ECAR during B-cell fate determination, using various reagents
described in Fig. 2 (Supplementary Fig. 4b). However, there was
no obvious involvement of OCR and ECAR in B-cell differ-
entiation. Because mROS play key roles in various cell func-
tions35,39,40, we evaluated their levels in P1 and P2 cell
populations. We observed a ROShigh population in P1 cells
(Fig. 3d and Supplementary Figs 1d and 2b,c). We also
investigated the roles of ROS generation during B-cell fate
determination using various reagents described in Fig. 2. ROS
were induced by P1 cell-promoting reagents, whereas their levels
were reduced by P2 cell-promoting reagents (Supplementary
Figs 6–8). This ﬁnding suggested that ROS promoted CSR but
suppressed PCD.
Protein levels in P1 cells were increased for Pax5, Bcl6, AID
and c-Myc, which have been reported to promote CSR. Levels of
Blimp1, Irf4 and Xbp1 proteins were higher in P2 than in P1 cells.
The expression level of c-Myc increased in P1 cells, whereas that
of Pax5 signiﬁcantly decreased in P2 cells (Fig. 3e). These
expression patterns were consistent with our hypothesis that P1
and P2 cells are cell populations precommitted to CSR and PCD.
Differential haeme synthesis in P1 and P2 cell populations.
Because Bach2 promotes CSR and inhibits PCD via the repression
of Blimp1 expression21,41, the reduced level of Bach2 correlates
strongly with reciprocal Blimp1 expression in the normal course
of B-cell activation. However, we found signiﬁcant expression
levels of both Blimp1 and Bach2 in P2 cells (Fig. 3e). Expression
levels of Bach2 and Bcl6 were similar between P1 and P2 cells. We
ﬁrst determined the haeme levels that inhibit Bach2 function36.
Haeme levels were higher in P2 cells than in P1 cells (Fig. 4a). In
vivo-generated P2 cells also showed higher haeme levels than P1
cells (Fig. 4a). These results indicated a direct relationship
between haeme levels and mitochondrial function. We then
investigated the possible role of ROS in haeme synthesis. Haeme
levels (Fig. 4b,c) were increased and PCD (Figs 2 and 4d and
Supplementary Fig. 9) was promoted after treatment of P1 cells or
activated B cells with ascorbic acid or MitoTEMPO, a
mitochondria-targeted antioxidant. In MitoTEMPO treated
cells, cellular ROS level was little reduced by day 4
(Supplementary Fig. 9c). We accordingly performed a time-
course analysis of cellular ROS and found an antioxidant effect of
MitoTEMPO on day 2 cells (24 h after MitoTEMPO treatment,
Supplementary Fig. 9c). These data indicated that ROS at early
time points was important in B-cell fate determination.
TPP cation is usually used as a carrier for targeting antioxidant
to mitochondria. Because MitoTEMPO also uses TPP, TPP is a
suitable control for assessing antioxidant function of Mito-
TEMPO. However, TPP was toxic to activated B cells, because cell
numbers of TPP-treated cells decreased (Supplementary Fig. 10a).
TPP, unlike MitoTEMPO, has no speciﬁc role in CSR and PCD,
as shown in Supplementary Fig. 10b. TPP inhibited CSR and
PCD in a dose-dependent manner. These results collectively
suggested that mROS inhibited haeme synthesis and promoted
CSR.
mROS interfere with addition of ferrous ions to PpIX. The
generation of 5-aminolevulinic acid (ALA) catalysed by ALA
synthase is the initial step in haeme synthesis. As the ﬁnal step,
ferrous ion is incorporated into protoporphyrin IX (PpIX) by
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7750
4 NATURE COMMUNICATIONS | 6:6750 | DOI: 10.1038/ncomms7750 |www.nature.com/naturecommunications


































































LY294002 (DMSO) - Pl3K inhibitor
AZD5365 (DMSO) - AKT inhibitor
Oligomycin (EtOH)
Total IgG1 Total CD138 Total IgG1 Total CD138
Total IgG1 Total CD138
Total IgG1 Total CD138
Total IgG1 Total CD138




















































































































Figure 2 | Association of mitochondrial status with activated B-cell fate. Flow cytometric analysis of mitochondrial status monitored by MitoTracker
staining (left) or differentiation monitored by CD138 (right) and IgG1 (middle) expression after 4 days of culture with LPSþ IL-4 in the presence or absence
of the indicated reagents. a is the control for b–h. i is the control for j–l. m is the control for n. Data shown are representative of three independent
experiments. DMSO, dimethylsulphoxide.
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ferrochelatase (Fech). Haeme oxygenase-1 (HO-1) expression is
induced by haeme to reduce the cellular haeme level. In contrast,
CD71, the transferrin receptor, is required for iron uptake. The
levels of haeme synthesis were not simply explained by expression
levels of ALA synthase, CD71, or HO-1 (Supplementary Fig. 11).
We accordingly investigated the processes of haeme synthesis
affected by mROS by comparing the amounts of PpIX in the P1
and P2 cell populations. As shown in Fig. 4e, PpIX levels in P1
cells were higher than those in P2 cells, indicating that substrates
and enzymes required to form the haeme precursor PpIX are not
impaired but rather enhanced in the P1 cell population. We next
assessed PpIX generation by the addition of ALA, whose synthesis
is the rate-limiting step in haeme synthesis. PpIX levels were
higher in P1 than in P2 cells, and this effect was counteracted by
the treatment of P1 cells with MitoTEMPO (Fig. 4e–g). PpIX
accumulation was simply explained by enhanced PpIX produc-
tion or inhibition of the addition of ferrous ions to PpIX. The
haeme level in P1 cells was low, and the antioxidant reversed the
impairment of haeme synthesis (Fig. 4a–c). These data collec-
tively suggested that mROS inhibited haeme synthesis by























































































































































Figure 3 | Characterization of P1 and P2 cell populations. (a) Transmission electron microscopy of FACS-sorted P1 and P2 cells. Red arrow indicates
mitochondria. Mitochondria in P1 cells have been damaged during the sorting procedure. A larger endoplasmic reticulum in developing P2 cells is shown
(right). Scale bar, 2mm. (b) OCR and ECAR of sorted P1 and P2 cells. **Po0.005 (two-tailed Student’s t-test). (c) ATP levels in sorted P1 and P2 cells.
*Po0.05 (two-tailed Student’s t-test). (d) Flow cytometric analysis of ROS and the mitochondrial status by MitoTracker, CM-H2DCFDA, and MitoSOX
staining. (e) Western blotting analysis of unsorted (W) and sorted P1 and P2 cells. Data shown are representative of at least two independent experiments.
Data are shown as mean±s.e.m.
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interfering with the addition of ferrous ions to PpIX. However,
the precise mechanisms by which mROS inhibited haeme
synthesis await further investigation.
Haeme synthesis plays a key role in fate determination. To
further conﬁrm the role of de novo haeme synthesis in B-cell fate
determination, we treated in vitro-activated B cells with ALA and
CoCl2, a component of cobalt protoporphyrin (CoPP; not a
substrate for HO-1 but an inhibitor of Bach function)42.
Consistently with the increased haeme level after the addition
of ALA (Fig. 5a), PCD was promoted despite the high ROS
level (Fig. 5b,c). This response strongly indicated that haeme
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Figure 4 | Differential haeme synthesis in P1 and P2 cell populations. (a) Haeme levels in sorted P1 and P2 cells from in vitro-activated B cells (left) or GC
B cells in an immunized spleen (right). (b) Haeme levels in sorted P1 cells treated with indicated antioxidants. (c) Haeme levels in in vitro-activated B cells
treated with indicated antioxidants. (d) Flow cytometric analysis of the differentiation status monitored by CD138 and IgG1 expression after 4 days of
culture with LPSþ IL-4 in the presence or absence of MitoTEMPO. (e) Flow cytometric analysis of PpIX ﬂuorescence in P1 and P2 cells. In vitro-activated B
cells treated with indicated reagents were assessed. (f) Mean ﬂuorescence intensities (MFI) of PpIX as shown in (e) are plotted. (g) Increased MFI of PpIX
after treatment with indicated reagents is plotted. Data shown are representative of three independent experiments. Data are shown as mean±s.e.m.
**Po0.05, ***Po0.005. (two-tailed Student’s t-test).
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interpretation was further supported by the ﬁnding that PCD was
enhanced after the treatment of activated B cells with CoCl2,
which increases the amounts of metalloporphyrin, a molecule
consisting of haeme and CoPP, and ROS level (Fig. 5a–c).
Bach2 inhibits P2 cell generation. We next examined the
effects of Bach2 on mitochondrial status, because the mROS–
haeme relationship was based on modulating Bach2 function in
P1 and P2 cells. As shown in Fig. 6a, more P2 cells were
generated from Bach2 / B cells than from wild-type cells,
consistent with the observation that P2 cells contain more haeme
than do P1 cells (Fig. 4a). These ﬁndings supported the notion
that Bach2 function was suppressed in P2 cells and indicated
that Bach2 was required for both P1 cells and CSR. Because
Blimp1 expression is increased in Bach2 / B cells, we next
investigated whether Blimp1 is required for P2 cell generation,
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Figure 5 | Differential production of ROS instructs cell fates in activated B cells. (a) Metalloporphyrin levels of in vitro-activated B cells treated with
indicated reagents. Metalloporphyrin in control or ALA-treated cells consisted of haeme, whereas that in CoCl2-treated cells consisted of haeme and CoPP.
***Po0.005 (two-tailed Student’s t-test). (b) Flow cytometric analysis of mitochondrial status monitored by MitoTracker staining and differentiation status
monitored by CD138 and IgG1 expression on day 4. ***Po0.005 (two-tailed Student’s t-test). (c) Flow cytometric analysis of mitochondrial status and
cellular ROS monitored by MitoTracker DeepRed and CM-H2DCFDA (left) staining or mitochondrial status and mROS monitored by MitoTracker Green
and MitoSOX (right) staining. **Po0.05, ***Po0.005. (two-tailed Student’s t-test) FACS Data shown in b,c are representative of three independent
experiments. Data are shown as mean±s.e.m.
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In these mice, Blimp1 was replaced with GFP, so that GFP
expression was under the control of endogenous Blimp1
regulatory elements, indicating that Blimp1-expressing cells
was easily identiﬁed by GFP expression. Because committed cells
to PCD, but not to CSR, express Blimp1, GFPþ cells was
PC-committed populations. P2 cells were generated from
Blimp1-expressing cells (GFPþ cells in Blimp1þ /GFP
B cells, Fig. 6b upper column) and could not be observed in
Blimp1GFP/GFP B cells (Fig. 6b lower column). These data indi-
cated that P2 cells were generated in a manner depending
on Blimp1 function and suggested that the mitochondrial
status of P2 cells were a physiological property of differentiated
plasma cells.
Differential ROS production provides instructive signals. As
shown in Fig. 1c, commitment of activated B cells to CSR or PCD
was predicted by their mitochondrial status. P1 cells, which
contained higher mitochondrial mass and membrane potential,
preferentially underwent CSR, whereas P2 cells, which contained
lower mitochondrial mass and membrane potential, differentiated
into plasma cells. Bach2 function is required for CSR, and
reduced activity of Bach2 promotes PCD. However, the expres-
sion level of Bach2 differed little between P1 and P2 cells (Fig. 3e).
Thus, the differential regulation of Bach2 activity is key in these
cell fate-determination processes. Bach2 function was maintained
by inhibition of haeme synthesis by mROS produced in P1 cells
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Figure 6 | Differential ROS production provides instructive signals for fates of activated B cells. (a) Flow cytometric analysis of mitochondrial
membrane potential and size monitored by MitoTracker staining (left) or differentiation of B cells monitored by CD138 and IgG1 expression (middle and
right) in LPSþ IL-4-stimulated Bach2 / or WT B cells. (b) Flow cytometric analysis of mitochondrial membrane potential monitored by MitoTracker
staining and GFP expression (left) or differentiation of B cells monitored by CD138 and IgG1 expression (middle and right) in LPSþ IL-4-stimulated
Blimp1G/G or Blimp1G/þ B cells. (c) Diagrammatic representation of experimental protocol. Flow cytometric analysis of differentiation of sorted ROSlow(L)
and ROShigh(H) cells (top and middle) and proliferation (bottom). (d) Western blotting analysis of unsorted (W) and sorted ROSlw(L) and ROShigh(H)
cells. Data shown are representative of at least two independent experiments.
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allowing the expression of Bach2 target genes such as Blimp1
(Fig. 3e). P2 cells appear to arise from plasma cell-committed
populations (Figs 3e and 6b). To determine whether the same
scenario is applicable in the initial step of cell fate determination,
we evaluated the differentiation capacity of ROShigh and ROSlow
cells within P1 cells. Between ROShigh and ROSlow cells derived
from the P1 cell population, we found no differences in protein
levels of transcription factors essential to CSR and PCD (Fig. 6d).
These results suggested that cells at this stage are not committed
to either differentiation pathway. When undifferentiated ROShigh
and ROSlow cells were collected and cultured for an additional 2.5
days, ROShigh cells underwent predominantly CSR, whereas
ROSlow cells differentiated into plasma cells (Fig. 6c). In addition,






























































Figure 7 | Schematic representation of models of B-cell differentiation during normal course of immune reaction. On activation, B cells acquire
mitochondrial mass and membrane potential (and are called P1 cells) and proliferate. Stochastic differences in mitochondrial activity within P1 cells
generate diverse P1 cells having various ROS amounts (in this scheme, they are simply classiﬁed into two groups, P1 ROShigh and P1 ROSlow cells). In
addition to the signalling function, excess amounts of ROS have another function of attenuating haeme synthesis. In general, newly generated haeme that
cannot bind to haeme proteins is degraded immediately by HO-1. Haeme that binds to high- but not to low-afﬁnity haeme-binding proteins (such as
Bach2), are retained for a longer period. Thus, the effects of haeme on the regulation of low-afﬁnity haeme-binding proteins are limited. Moreover,
increasing amounts of free haeme induce HO-1 expression, which enhances the activity of free haeme clearance. Accordingly, the level of effective haeme
concentration that regulates low-afﬁnity haeme-binding proteins cannot be achieved by transient elevation of haeme contents. In P1 ROSlow cells, the
upregulation of haeme turnover, which supports a continuous haeme supply, inhibits Bach2 function and promotes the PCD program (from P1 ROSlow to P2
cells). Theoretically, initial changes might occur at any steps described in this scheme. For example, HO-1-dependent degradation of haeme provides an
antioxidant, which can cause reduction of ROS level. The important steps in the respective immune reactions await identiﬁcation. The majority of naı¨ve B
cells are also P2 cells, but almost all the cells show increased mitochondrial mass, membrane potential (Fig. 1a) and Bach2 protein expression after
activation (not shown). Accordingly, P1 and P2 populations observed in naı¨ve B cells may be different from P1 and P2 populations of activated B cells.
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ROShigh cells, but appearance of P2 cells was observed in cultured
in ROSlow cells (Fig. 6c). Because CSR and PCD are inﬂuenced by
cell proliferation, numbers of cell divisions were assessed by
BRSE. As shown in Fig. 6c, there was little difference in the cell
division numbers between these populations. These results indi-
cated that change in mROS generation was the cause of the cell
fate decision after B-cell activation. These ﬁndings together
indicate that fate determination of activated B cells is dependent
on ROS level, which negatively regulates haeme synthesis. Halﬂife
of Bach2 protein was longer than that of Pax5 protein, because
signiﬁcant amount of Bach2 protein was observed in 5 days-
cultured B cells (Supplementary Fig. 12). These data indicated
that quantitative regulation of haeme plays an important role in
promoting PCD. In other words, PCD is a reversible state before
loss of Bach2 protein. Our results show the mechanism of
induction of differentiation in the lineage commitment process
of B cells (Fig. 7). In general, commitment to speciﬁc lineages of
haematopoietic cells is an integrated interpretation of instructive
and stochastic signals14–17,43,44. Precise understanding of the
mechanism of B-cell fate determination requires further
identiﬁcation of the mechanisms by which levels of ROS and
haeme synthesis are regulated by instructive signals and by which
haeme functions as a signalling molecule.
Discussion
Fate determination of activated B cells toward CSR or PCD
appears to be an intracellular stochastic process14,15. However,
the underlying stochastic changes resulting in the initiation of
either pathway are incompletely understood.
In this study, we identiﬁed mROS, which reﬂect individual
mitochondrial status, as a signal for the initiation of fate
determination of activated B cells. mROS promoted CSR and
suppressed PCD by attenuating haeme synthesis because haeme
inhibits Bach2 function36. The underlying mechanism of the
inhibition of haeme synthesis is unknown. According to our
combined experimental results, mROS inhibited the addition of
ferrous ions to PpIX in mitochondria. There are at least three
ways by which this inhibition may occur—mROS may inhibit
haeme synthesis by inhibiting Fech activity; mROS may inhibit
the reduction of ferric ion to ferrous ion, a substrate of Fech, in
mitochondria; or there may be a defect in iron availability in
mitochondria. In this regard, involvement of Fech in CSR and
PCD was examined in vivo. As shown in Supplementary Fig. 13a,
CSR was enhanced in mice treated with Fech inhibitor, but its P
value did not meet the criteria of statistical signiﬁcance.
Additionally, mitochondrial function in activated B-cell fate
determination was investigated in vivo. Enhanced CSR and
reduced PCD were observed in complexI/III-inhibitor-treated
mice (Supplementary Fig. 13b).
B cells, having high afﬁnity to B-cell receptors (BCR) and
antigens, differentiate preferentially into plasma cells, indicating
that antigen recognition strength is an instructive signal for PCD.
PI3K and Akt activities affect activated B-cell fates38. The PI3K–
Akt pathway, downstream of BCR signalling, inhibits CSR by
repressing AID gene expression via Foxo1 and Foxo3a
phosphorylation, and promotes PCD by inducing Blimp1
expression. However, the mechanism by which PI3K–Akt
induces Blimp1 is unknown. Another downstream signal of
BCR, Erk, is also required for PCD. In this case, Blimp1
expression is induced by Erk-dependent Elk1 phosphorylation45.
Irf4 is required for both CSR and PCD12,13. The antigen-binding
afﬁnity of BCR regulates the magnitude of Irf4 expression and
acts as a dose-dependent regulator of activated B-cell fates12,13. A
weaker BCR signal induces a lower Irf4 level, resulting in CSR. In
contrast, increased antigen afﬁnity augments BCR signalling-
mediated Irf4 expression and promotes PCD. Dose-dependent
cell fate determination by Irf4 is achieved via discrimination
between the afﬁnities of various target sequences, as suggested
previously7,46. Lower-afﬁnity recognition sequences of Irf4 are
occupied by Irf4 in differentiating plasma cells, which promote
PCD by inducing the gene sets essential for PCD12. In T cells, Irf4
expression is also controlled by T-cell receptor afﬁnity47,
indicating the presence of a similar regulatory network in T
cells. Thus, a relationship between the amount of Irf4 and cell fate
determination has been clearly demonstrated. However, the
mechanisms by which the strength of BCR signalling is sensed
and Irf4 expression is regulated are unknown.
Inhibition of the PI3K–Akt signal strongly promotes P1 cell
generation, accompanied by reduced PCD and enhanced CSR. In
other words, the PI3K–Akt signal, a downstream signal of BCR,
promotes P2 cell generation, which in turn promotes PCD. An
increased amount of mROS is produced in the P1 cell population,
attenuating haeme synthesis. Bach2 function is maintained in the
P1 cell population and suppressed in the P2 cell population
because Bach2 is negatively regulated by haeme. In differentiating
plasma cells, increasing amounts of haeme inhibit Bach2 function
and in turn promote Blimp1 expression because Blimp1 is a
direct target of Bach2 in B cells. Recent reports have shown that
Irf4 is a direct target of Bach2 in macrophages48 or regulatory T
cells49, indicating that reduced Bach2 function in the P2 cell
population is responsible for the induction of Irf4 gene
expression. Alternatively, the involvement of another
transcriptional repressor also regulated by haeme is an
attractive mechanism by which Irf4 expression may be induced
in haeme-rich P2 cells. Mitf is a strong candidate as a
transcriptional repressor of Irf4 in B cells50, and contains three
Cys-Pro (CP) motifs involved in haeme binding. The involvement
of Mitf in this haeme-decoding system awaits further elucidation.
In summary, we provide a model to explain how instructive
and stochastic signals of activated B cells are integrated via
changes in mitochondrial function that modulate mROS levels.
Besides the function of mROS as signals for various cell fate
determinations, mROS attenuate haeme synthesis, and the
amount of haeme also plays a key role in cell fate determination
of activated B cells by regulating the activities of haeme-binding
transcription factors including Bach2. Accumulating evidence
indicates that self-renewal and differentiation of HSCs are
dependent on mROS, although the precise role of mROS in
these processes is unclear. Thus, our ﬁndings provide insight into
the fundamental roles of haeme synthesis, which is regulated by
mitochondrial status, in cell fate determination processes.
Identiﬁcation of mROS as inhibitors of haeme synthesis has
important implications for understanding not only B cells but
also HSC biology, and may be applicable to the treatment of
hematopoietic disorders.
Methods
Mice. This study received ethics approval from the Institutional Review Board of
Kyoto University (reference number, Med Kyo13086). Bach2 / (provided by Dr
Igarashi, Tohoku University), Blimp1-GFP (provided by Dr Nutt, The Walter and
Eliza Hall Institute of Medical Research) and wild-type mice on C57BL/6 genetic
background were maintained in a speciﬁc pathogen-free mouse facility, and male
mice were used at 8–12 weeks of age. Procedures involving animals and their care
followed the guidelines for animal treatment of the Institute of Laboratory Ani-
mals, Kyoto University.
Cell preparation and in vitro culture. Naı¨ve B cells were prepared by magnetic cell
sorting using anti-CD43 microbeads (130-49-801; Miltenyi Biotec). Puriﬁed splenic
B cells (5 105 cellsml 1) were cultured in RPMI 1640 medium (11875-093;
Gibco) supplemented with 10% fetal bovine serum (FBS) and 2-mercaptoethanol
(50mM; Nacalai Tesque) in the presence of LPS (40mgml 1; L7136/015K4074/
014K4112/086K4056 and L3755/102M4018V; Sigma) and IL-4 (20 ngml 1; R&D
systems) or anti-mouse CD40 (HM40-3) antibody (1mgml 1; 553721; BD
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PharMingen) and IL-4 for 4 days. In some experiments, cells cultured for 2.5 days
were sorted by ﬂow cytometry using FACSAria (Becton Dickinson) and restimu-
lated with LPSþ IL-4 in the presence of the indicated reagents (Figs 1c and 6d).
CFSE or BRSE labelling. Puriﬁed splenic naı¨ve B cells (5 106 cells) were stained
with 500ml of 5-mM CFSE solution (345-06441; DOJINDO) in a CO2 incubator at
37 C for 10min. Sorted cells were stained with 500 ml of 5-mM BRSE solution (D-
2219; Molecular Probes) in a CO2 incubator at 37 C for 10min.
Flow cytometric analysis and cell sorting. After cultured cells were washed with
prewarmed no-glucose RPMI 1640 medium (11879020; Gibco) supplemented with
10% FBS (staining buffer), 1.5 106 cells were resuspended in 1ml of staining
buffer containing MitoTracker Green (20 nM; M7514; Invitrogen), MitoTracker
DeepRed (20 nM; M22426; Invitrogen), MitoSOX (5 mM; M36008; Invitrogen),
CM-H2DCFDA (5mM; C6827; Invitrogen), TMRM (40 nM; 9105; Immu-
nochemistry Technologies) or CellROX DeepRed (5 mM; C10422; Life Technolo-
gies) and incubated in a CO2 incubator at 37 C for 30–40min. Stained cells were
washed with 1ml of prewarmed staining buffer and used for FACS (ﬂuorescence-
activated cell sorting) analysis, cell sorting or further staining with antibodies.
Normal rabbit serum (10%) containing Fc Block (2.4G2; BD PharMingen) was
used as blocking reagent. For immunized spleen cells, 5 106 cells were incubated
with 1ml of staining buffer containing MitoTracker Green (40 nM) and DeepRed
(40 nM), and acid wash treatment was applied to remove surface-bound immu-
noglobulin before antibody staining. MitoTracker-stained 5 106 spleen cells were
suspended in 10 ml of acid solution (equal volumes of cold 0.1M acetic acid, pH 4
and solution containing 0.17M NaCl and 0.01M KCl mixed before use), incubated
on ice for 1min and neutralized by the addition of 1ml of cold Tris buffer (0.03M
Tris, pH 7.4, 0.8 PBS, 2% FCS). The following antibodies (1/300 diluted) were
used for staining: biotin-labelled anti-mouse IgG1 (553441; BD PharMingen),
phycoerythrin (PE)-conjugated anti-mouse CD138 (553714; BD PharMingen),
Brilliant Violet 421-conjugated anti-mouse CD138 (562610; BD PharMingen), PE/
Cy7-conjugated anti-mouse B220 (552772; BD PharMingen), PE-conjugated anti-
mouse FAS (554258; BD PharMingen), streptavidin–Brilliant Violet 421-con-
jugated (405226; Biolegend) and streptavidin–Brilliant Violet 570-conjugated
(405227; Biolegend). For sorting immunized spleen cells, T-cell depletion was
performed using IMAG and anti-Thy1.2 beads (551518; BD Biosciences) before
staining with MitoTracker. Cytometric analysis and sorting of in vitro cultured and
immunized cells was performed using FACSAria.
Immunization. For T-cell-dependent immune response, NP-chicken gamma glo-
bulin (100 mg; NP-CGG; Biosearch Technologies) in complete Freund’s adjuvant
(Difco) was intraperitoneally injected. For T-cell-independent immune response,
NP-Ficoll (50 mg) in PBS was intraperitoneally injected.
Reagents used in vivo. During T-cell-independent immune reaction, N-methyl
protoporphyrin (16 g kg 1 per day; MPP; Fech inhibitor; NMP576; Frontier Sci-
entiﬁc) or N-benzylguanidine acetate (10 g kg 1 per day; NBA; complexes I, III
inhibitor; SC-279892; SantaCruz) were intraperitoneally injected.
Reagents used in in vitro culture. The following reagents were added to in vitro
culture from days 2.5 to 4: methyl pyruvate (10mM; 371173; Sigma), methyl
malate (5mM; 355-17971; Wako), etomoxir (90 mM; E1905; Sigma), rotenone
(120 nM; R8875; Sigma), metformin (1mM; 150959; SIGMA), oligomycin (1 nM;
O4876; Sigma), 2-deoxy-D-glucose (200 mM; 154-17-6; SIGMA), haemin (30 mM;
H9039; Sigma), ascorbic acid (200 mM; A7506; Sigma), MitoTEMPO (64 mM; ALX-
430-150; Enzo Life Science) and TPP (64 mM; 309567; SIGMA); from days 1 to 4:
LY294002 (3mM; 1667; Biovision), AZD5363 (5 mM; S8019; Selleckchem) and 5-
ALA hydrochloride (450 mM; 3785; Sigma); and from days 3 to 4: cobalt (II)
chloride (150 mM; 232696; Sigma).
For OCR and ECAR assay, all the reagents were added at 36 h of culturing and
incubated for 12 h. Exposing duration of cells to reagents was therefore from 36 to
48 h of culturing.
Extracellular ﬂux analysis. OCR and ECAR were measured in XF media
(unbuffered RPMI 1640 containing 1% FBS, 11mM glucose, 2mM glutamine and
1mM pyruvate) under basal conditions and in response to 1 mM oligomycin
(O4876; Sigma), 1 mM carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone and
1 mM antimycin A (A0149; Sigma) on the XF96 extracellular ﬂux analyzer (Sea-
horse Bioscience, Billerica, MA, USA). Basal OCR was calculated by subtraction of
the residual rate after antimycin A treatment. After culture with LPS and IL-4 for
2.5 days, B cells were stained with MitoTracker Green and DeepRed and sorted
using FACSAria. Sorted cells were cultured for 24 h under the same conditions to
allow recovery from the stress of sorting. These cells were resuspended in XF media
and were plated onto Seahorse cell plates (1 105 cells per well) coated with poly-
L-lysine hydrobromide (P2636; Sigma).
To assess the effects of reagents on ECAR and OCR, we prepared cells treated
with various reagents under the conditions described in ‘Reagents used in in vitro
culture.’ After culture with LPS and IL-4 for 48 h, cells were resuspended in XF
media and were plated onto Seahorse cell plates (1 105 cells per well) coated with
poly-L-lysine hydrobromide (P2636; Sigma). OCR and ECAR were measured as
described above.
Protein extraction and western blot analysis. Proteins were extracted with lysis
buffer (Tri-HCl (pH 7.4), 150mM NaCl, 1mM EDTA, 1% NP-40, 0.5% NaDOC,
0.1% SDS, 1mM Na3VO4, 1mM phenylmethylsulphonyl ﬂuoride, 1 mgml 1 pep-
statin, 1mgml 1 aprotinine and 10mgml 1 leupeptine) for 20min on ice, and
protein amounts were quantiﬁed using Micro BCA Protein Assay Reagent (23235;
Pierce Chemical Co.). Whole-cell lysates (40mg per lane) were resolved on SDS–
polyacrylamide gels, electrotransferred onto polyvinylidene diﬂuoride membranes
and examined by immunoblot analysis. The primary antibodies used were anti-
PAX5 (610862; BD PharMingen), anti-BCL6 (#4242; Cell Signaling), anti-c-MYC
(NB600-302C; Novus Biologicals), anti-IRF4 (sc-6059; Santa Cruz), anti-BLIMP1
(NB600-235; Novus Biologicals), anti-XBP1 (sc-7160; Santa Cruz), anti-HO-1
(NBP1-97507; Novus Biologicals), anti-AID (provided by Dr Alt) and anti-GAPDH
(#2118; Cell Signaling). Full-sized scans of all western blots shown in Figs 3 and 6
and Supplementary Figs 11 and 12 are provided in Supplementary Fig. 14. Quan-
tiﬁcation of intensity was performed using an Image J (http://imagej.nih.gov/ij/).
Transmission electron microscopy. Sorted P1 and P2 cells (from B cells cultured
for 3 days) were plated onto a Lab-Tek Chamber Slide (177445; Nunc), coated with
poly-L-lysine hydrobromide and ﬁxed with 4% paraformaldehyde/2% glutar-
aldehyde. Sections were viewed with a Hitachi H-7650 transmission electron
microscope.
Reverse transcription–PCR. Total RNAs were extracted from cultured B cells with
TRIzol reagent (Gibco). Oligo (dT)-primed complementary DNAs were prepared
with reverse transcriptase. Complementary DNAs were subjected to PCR reactions
with the following primer pairs: Bach2 forward, 50-CGCTGTCGAAAGAGGAAG
CTGGAC-30 ; Bach2 reverse, 50-CCTGGATCTGCTCTGGACTCTGGA-30 ; Pax5
forward, 50-ATTGTCACAGGCCGAGACT-30 ; Pax5 reverse, 50-GCTGCAGGGC
TGTAATAGT-30 ; Gapdh forward, 50-CCATCACCATCTTCCAGGA-30; Gapdh
reverse, 50-CCTGCTTCACCACCTTCTT-30 .
Haeme quantiﬁcation. Sorted or cultured B cells (2 105) were suspended in
500 ml of saturated oxalic acid in water and heated at 121 C for 20min. Emission
peaks at 608 and 662 nm using 400 nm excitation were measured (Hitachi MPF-4).
Intracellular measurement of PpIX ﬂuorescence. Intracellular PpIX ﬂuores-
cence was evaluated by FACSAria (excitation 405 nm; emission, 625/20 nm ﬁlter).
Intracellular ATP quantiﬁcation. ATP was measured using an ATP determina-
tion kit (A22066; Invitrogen) according to the manufacturer’s instructions.
Statistical analysis. OCR, ECAR, ATP, protoporphyrin, haeme and metallopor-
phyrin amounts were compared by Student’s t-test. All reported P values were two-
tailed and P values o0.05 were considered to indicate signiﬁcance.
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